Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up

M. V. Mateos; P. Rodríguez-Otero; S. Z. Usmani; S. Kumar; J. Christine Ye; S. Atrash; Y. C. Cohen; H. Magen; H. Quach; M. P. Chu; S. Trudel; J. Richter; H. Chuah; M. Gatt; E. Medvedova; S. Raza; D. H. Yoon; T. Ishida; J. V. Matous; L. Rosiñol; K. Onodera; C. Maffucci; P. Thakkar; T. Henninger; L. O’Rourke; E. Scott; C. Heuck; J. Zhang; J. Zhou; N. Au; M. Krevvata; L. Pei; M. Festa; M. Takamoto; J. Lu

doi:10.3324/haematol.2026.s2.14055

Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up

M. V. Mateos^*
, P. Rodríguez-Otero
, S. Z. Usmani
, S. Kumar
, J. Christine Ye
, S. Atrash
, Y. C. Cohen
, H. Magen
, H. Quach
, M. P. Chu
, S. Trudel
, J. Richter
, H. Chuah
, M. Gatt
, E. Medvedova
, S. Raza
, D. H. Yoon
, T. Ishida
, J. V. Matous
, L. Rosiñol

K. Onodera, C. Maffucci, P. Thakkar, T. Henninger, L. O’Rourke, E. Scott, C. Heuck, J. Zhang, J. Zhou, N. Au, M. Krevvata, L. Pei, M. Festa, M. Takamoto, J. Lu

^*Corresponding author for this work

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1
Number of pages	1
Journal	Haematologica
Volume	111
Issue number	s2
DOIs	https://doi.org/10.3324/haematol.2026.s2.14055
State	Published - 2026

Access to Document

10.3324/haematol.2026.s2.14055

Cite this

Mateos, M. V., Rodríguez-Otero, P., Usmani, S. Z., Kumar, S., Ye, J. C., Atrash, S., Cohen, Y. C., Magen, H., Quach, H., Chu, M. P., Trudel, S., Richter, J., Chuah, H., Gatt, M., Medvedova, E., Raza, S., Yoon, D. H., Ishida, T., Matous, J. V., ... Lu, J. (2026). Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up. Haematologica, 111(s2), 1. https://doi.org/10.3324/haematol.2026.s2.14055

@article{c9cc8d60e26e4233a9f639c02923e098,

title = "Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up",

author = "Mateos, \{M. V.\} and P. Rodr{\'i}guez-Otero and Usmani, \{S. Z.\} and S. Kumar and Ye, \{J. Christine\} and S. Atrash and Cohen, \{Y. C.\} and H. Magen and H. Quach and Chu, \{M. P.\} and S. Trudel and J. Richter and H. Chuah and M. Gatt and E. Medvedova and S. Raza and Yoon, \{D. H.\} and T. Ishida and Matous, \{J. V.\} and L. Rosi{\~n}ol and K. Onodera and C. Maffucci and P. Thakkar and T. Henninger and L. O{\textquoteright}Rourke and E. Scott and C. Heuck and J. Zhang and J. Zhou and N. Au and M. Krevvata and L. Pei and M. Festa and M. Takamoto and J. Lu",

year = "2026",

doi = "10.3324/haematol.2026.s2.14055",

language = "אנגלית",

volume = "111",

pages = "1",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "s2",

}

Mateos, MV, Rodríguez-Otero, P, Usmani, SZ, Kumar, S, Ye, JC, Atrash, S, Cohen, YC, Magen, H, Quach, H, Chu, MP, Trudel, S, Richter, J, Chuah, H, Gatt, M, Medvedova, E, Raza, S, Yoon, DH, Ishida, T, Matous, JV, Rosiñol, L, Onodera, K, Maffucci, C, Thakkar, P, Henninger, T, O’Rourke, L, Scott, E, Heuck, C, Zhang, J, Zhou, J, Au, N, Krevvata, M, Pei, L, Festa, M, Takamoto, M & Lu, J 2026, 'Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up', Haematologica, vol. 111, no. s2, pp. 1. https://doi.org/10.3324/haematol.2026.s2.14055

Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up. / Mateos, M. V.; Rodríguez-Otero, P.; Usmani, S. Z. et al.
In: Haematologica, Vol. 111, No. s2, 2026, p. 1.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease

T2 - Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up

AU - Mateos, M. V.

AU - Rodríguez-Otero, P.

AU - Usmani, S. Z.

AU - Kumar, S.

AU - Ye, J. Christine

AU - Atrash, S.

AU - Cohen, Y. C.

AU - Magen, H.

AU - Quach, H.

AU - Chu, M. P.

AU - Trudel, S.

AU - Richter, J.

AU - Chuah, H.

AU - Gatt, M.

AU - Medvedova, E.

AU - Raza, S.

AU - Yoon, D. H.

AU - Ishida, T.

AU - Matous, J. V.

AU - Rosiñol, L.

AU - Onodera, K.

AU - Maffucci, C.

AU - Thakkar, P.

AU - Henninger, T.

AU - O’Rourke, L.

AU - Scott, E.

AU - Heuck, C.

AU - Zhang, J.

AU - Zhou, J.

AU - Au, N.

AU - Krevvata, M.

AU - Pei, L.

AU - Festa, M.

AU - Takamoto, M.

AU - Lu, J.

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105039050375

U2 - 10.3324/haematol.2026.s2.14055

DO - 10.3324/haematol.2026.s2.14055

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:105039050375

SN - 0390-6078

VL - 111

SP - 1

JO - Haematologica

JF - Haematologica

IS - s2

ER -

Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up

Access to Document

Other files and links

Cite this